Skip to main content
Timothy Fenske, MD, Oncology, Milwaukee, WI

TimothySFenskeMDMS

Oncology Milwaukee, WI

Hematologic Oncology

Professor of Medicine

Dr. Fenske is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Fenske's full profile

Already have an account?

  • Office

    Froedtert / MCW Clinical Cancer Center
    9200 West Wisconsin Avenue
    Milwaukee, WI 53226
    Phone+1 414-805-4633
    Fax+1 414-805-4606

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2002 - 2005
  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsResidency, Internal Medicine, 1999 - 2002
  • University of Wisconsin School of Medicine & Public Health
    University of Wisconsin School of Medicine & Public HealthClass of 1999

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 2000 - 2025
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Murphy Award for Clinical Excellence Medical College of WI, Dept of Medicine, 2012
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Short Time to Treatment Is Associated with Inferior Survival in Newly Diagnosed Patients with Mantle Cell Lymphoma
    Timothy S. Fenske, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Comparison of Reduced-Intensity Conditioning (RIC) Regimens for Allogeneic Hematopoietic Cell Transplantation (alloHCT) for Classical Hodgkin Lymphoma (cHL):a Center f...
    Timothy S. Fenske, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Comparison of Reduced-Intensity Conditioning (RIC) Regimens for Allogeneic Hematopoietic Cell Transplantation (alloHCT) in Non-Hodgkin Lymphomas (NHL)-a Center for Int...
    Timothy S. Fenske, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Lectures

  • Five-Year Outcomes of SWOG S0: A Randomized Phase II US Intergroup Study of R-HCVAD Vs. R-Bendamustine Followed By Autologous Stem Cell Transplant for Patients with Ma... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

  • Can We Omit Auto-SCT in Patients with Mantle Cell Lymphoma with Undetectable MRD Post-Induction?
    Can We Omit Auto-SCT in Patients with Mantle Cell Lymphoma with Undetectable MRD Post-Induction?January 6th, 2025
  • No Stem Cell Transplant Needed for Mantle Cell Lymphoma?
    No Stem Cell Transplant Needed for Mantle Cell Lymphoma?December 15th, 2024
  • Mantle Cell Lymphoma Patients May Not Need Stem Cell Transplant
    Mantle Cell Lymphoma Patients May Not Need Stem Cell TransplantDecember 10th, 2024
  • Join now to see all

Committees

  • Member, ECOG Lymphoma Committee 2010 - Present
  • Member, CIBMTR Lymphoma Working Committee 2006 - Present